CARDIOVASCULAR RISK PROFILES OF MONOTHERAPY VS. COMBINATION THERAPY IN TYPE 2 DIABETES. Review Journal of Neurological & Medical Sciences Review, [S. l.], v. 3, n. 7, p. 140–147, 2025. DOI: 10.63075/7swvcz45. Disponível em: https://nmsreview.org/index.php/rjnmsr/article/view/455. Acesso em: 23 oct. 2026.